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Abstract A suppression subtractive hybridization technique was
used to identify reactive oxygen species (ROS)-regulated genes
in rat vascular smooth muscle cells. Three genes out of 89 clones,
identified as fibronectin, p105 coactivator and ECA39, showed
increased expression after treatment with H2O2. The mRNA
expressions of these three genes were induced in a time- and dose-
dependent manner, independent of protein kinase C activation.
Immunohistochemical staining showed that the p105 coactivator
expression was markedly induced in the neointima of balloon-
injured rat carotid arteries. These results suggest that ROS may
play an important role in the development of atherosclerosis by
regulating the gene expressions we identified in this study.
z 1999 Federation of European Biochemical Societies.
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1. Introduction
Recently, there has been a growing interest in the potential
role of reactive oxygen species (ROS) in the pathogenesis of
cardiovascular disease. Experimental animal studies have in-
dicated that increased ROS production is associated with risk
factors of atherosclerosis such as hypertension [1], hypercho-
lesterolemia [2] and diabetes [3]. Indeed, clinical mass studies
[4,5] have also provided support for the signi¢cance of ROS in
the development of atherosclerosis. Induction of ROS causes
an increase in peroxidized lipids such as oxidized LDL and
thus enhances the foam-cell formation of macrophages [6]
in¢ltrating into the subendothelial space and promotes migra-
tion of vascular smooth muscle cells (VSMC) [7]. In addition
to such a macrophage-mediated mechanism, ROS can directly
stimulate DNA synthesis and accelerate proliferation of
VSMC [8], which plays a key role in the development of
atherosclerosis. Although, it has been demonstrated using
the candidate gene approach that ROS are potential modula-
tors of growth factor gene expressions in VSMC: among the
targets of ROS activation are heparin-binding epidermal
growth factor-like growth factor [9], insulin-like growth factor
I [10] and several growth-related proto-oncogenes including c-
myc and c-fos [11], the overall examination of the genes im-
plicated in ROS-mediated atherosclerosis. Thus, ROS seem to
be involved in the development of atherosclerosis through a
complicated pathway but the details of the mechanisms re-
main to be clari¢ed.
In this study, to make an approach to the mechanism for
ROS-mediated atherosclerosis, we sought to identify ROS-in-
duced gene expressions in VSMC using the suppression sub-
tractive hybridization (SSH) technique [12].
2. Materials and methods
2.1. Cell culture
VSMC were isolated from the thoracic aortas of 200^250 g
Sprague-Dawley rats as described previously [13]. Cells were grown
in DMEM supplemented with 10% heat-inactivated fetal calf serum
(FCS), 100 U/ml penicillin and 100 Wg/ml streptomycin in a humidi-
¢ed 5% CO2 atmosphere at 37‡C. Cells at passages 5^15 were used for
experiments.
2.2. Isolation of poly(A)+RNA
Polyadenylated RNA was isolated using Oligotex-dT306Supers
(Nippon Rosche, Japan Synthetic Rubber, Japan) according to the
recommendations of the manufacturer.
2.3. Generation of a subtracted library by SSH
SSH was performed using the Clontech PCR-Select cDNA Subtrac-
tion kit (Clontech Laboratories, Palo Alto, CA, USA) following the
manufacturer’s recommendations. Starting material consisted of 2 Wg
H2O2-stimulated VSMC mRNA (‘tester’) and 2 Wg non-stimulated
VSMC mRNA (‘driver’). Products from the secondary polymerase
chain reactions (PCRs) were inserted into pCR 2.1 using a T/A clon-
ing kit (Invitrogen, San Diego, CA, USA).
2.4. Northern blot analyses
Northern blot analysis followed standard procedures [14] with some
modi¢cations. Total RNA was isolated from VSMC before and after
3 h treatment with 200 WM H2O2. Twenty Wg of the total RNA was
size-fractionated by 1.2% agarose gel electrophoresis and transferred
to a nylon membrane. The probes used were 32P-labelled cloned
cDNA inserts which were released from the pCR 2.1 vector by EcoRI
digestion. The 950 bp NcoI fragment of mouse c-fos cDNA, which
was kindly provided from Dr Syuichi Hirai (Yokohama City Univer-
sity, Yokohama, Japan) was also used as a probe. After hybridization
with the labelled probes at 42‡C, the membrane was washed twice
with 2USSC (SSC: 1USSC, 15 nM sodium citrate, 150 nM NaCl,
pH 7.5), which contained 0.1% sodium dodecyl sulfate at 50‡C for
60 min, and was then washed with 0.2USSC and 0.1% SDS at 50‡C
for 30 min. Autoradiography was performed using an intensifying
screen at 380‡C and the exposure time was varied so that the band
intensity was kept within the linear range.
2.5. Sequencing analysis
DNA sequencing analyses were performed by the dideoxynucleotide
chain termination method [15] using an Applied Biosystems Model
310 automated DNA sequencer. Gene database searches were per-
formed through the National Center for Biotechnology Information
(National Institutes of Health, Bethesda, MD, USA) using the
BLAST network service.
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2.6. Balloon arterial injury of rat carotid artery
Male Sprague-Dawley rats (400 g, 14^16 weeks old) were anesthe-
tized with an intraperitoneal injection of sodium pentobarbital
(45 mg/kg). The bifurcation of the left common, internal and external
carotid arteries was temporarily ligated. A 2F balloon catheter
(Baxter Edwards Healthcare, Irvine, CA, USA) was introduced into
the external carotid artery and advanced to the distal ligation of
common carotid artery. The catheter was passed three times with
the balloon in£ated with saline to distend the common carotid artery.
The catheter was then withdrawn and the proximal external carotid
artery was ligated and the wound was closed. The right carotid ar-
teries were not damaged and served as controls. The animal studies
were conducted in accordance with the ‘Principles of laboratory ani-
mal care’ in NIH publication no. 85-23.
2.7. Immunohistochemistry
The carotid arteries were ¢xed with 10% phosphate-bu¡ered neutral
formalin by perfusion at 120 mm Hg pressure via the left ventricle at
14 days. After 5 min perfusion, the entire right and left carotid ar-
teries were removed and then ¢xed overnight by immersion in the
same ¢xative at 4‡C. The tissues were then washed twice with phos-
phate-bu¡ered saline (PBS). The middle third segment of injured or
uninjured common carotid artery was excised and dehydrated in etha-
nol series for para⁄n embedding and approximately 5 Wm sections
were prepared and mounted on slides. Before each incubation with
antibodies described below, the mounted sections were rinsed with
PBS three times. Immunohistochemical staining was performed using
an avidin-biotin-peroxidase kit (Vectastastain Elite ABC kit, Vector
Laboratories). The mounted sections were incubated with rabbit anti-
serum against human p100 coactivator (a homologue of rat p105
coactivator), which was generously provided by Dr Elliott Kie¡ (Har-
vard University, Boston, MA, USA) diluted 1:50 in PBS containing
1% BSA for 30 min. This was followed by incubation with biotinyl-
ated anti-rabbit IgG (Vector Laboratories), diluted 1:200 for 30 min,
used as the secondary antibody. The sections were then incubated
with ABC reagent for 30 min and positive reactions were visualized
by incubation with the peroxidase substrate solution containing 3,3P-
diaminobenzidine tetrahydrochloride (Zymed Laboratories, San Fran-
cisco, CA, USA).
3. Results
The SSH technique was utilized to identify ROS inducible
genes in VSMC. Messenger RNAs used for the SSH were
isolated from cultured VSMC before and after 3 h treatment
with 200 WM H2O2. A series of subtractive PCR ampli¢cation
and subsequent cloning into the plasmid vector (pCR 2.1)
yielded 147 cDNA clones. By comparison of the length of
the inserted cDNA fragments, 89 putatively independent
cDNA clones were identi¢ed. To determine whether or not
the expression of the cloned cDNA (gene) is increased by
H2O2, we performed Northern blot analyses. Using each iso-
lated cDNA clone as a probe, eight cDNAs (genes) out of 89
were found to be activated in response to H2O2 (Fig. 1). DNA
sequencing analyses for those eight cDNA clones identi¢ed
two as ¢bronectin and p105 coactivator (accession number
U83883). Another clone showed a high similarity with nucleo-
tide sequences to a mouse cDNA, ECA39 (79/84, 94%), and
was therefore judged as encoding the rat counterpart for
ECA39.
For the other ¢ve clones activated with H2O2 (arbi-
trarily termed as clones A^E), sequence similarities were
only found in the so-called expression sequence tags (ESTs).
Clones A and B matched previously reported ESTs in rat
(A, accession number C07195; B, C06962). Clones C and
D were similar to mouse ESTs (C, 96% (178 out of 186
nucleotides) homologous to AA032677; D, 98% (194 out
of 198) to AA119849). Clone E was similar to a human
EST (82% homologous to AA213802). Thus, clones C, D
and E were considered to be the rat counterparts of those
cDNAs.
Induction of ¢bronectin, p105 coactivator and ECA39
mRNA expressions was observed in a time-dependent man-
ner. After addition of H2O2, the level of ¢bronectin mRNA
increased at 0.5 h and returned to the near base line after 6 h.
The levels of p105 coactivator and ECA39 mRNA increased
at 3 h and there was a sustained increase of the levels of p105
coactivator and ECA39 mRNA until after 24 h (Fig. 2A).
Also, H2O2-induced ¢bronectin, p105 coactivator and
ECA39 mRNA expressions were observed in a dose-depen-
dent manner (Fig. 2B).
Because in several cell types including VSMC, oxidant-
mediated activation of protein kinase C (PKC) has been re-
ported [16^18], we examined if PKC is implicated in the ROS-
regulated expression of those three genes. VSMC were pre-
incubated with 100 nM 12-O-tetradecanoylphorbol-13-acetate
(TPA) for 24 h, during which PKC is down-regulated by
persistent treatment with TPA [19]. After this pretreatment,
the cells were treated with 200 WM H2O2 for the indicated
time. The results were shown in Fig. 2C. To con¢rm complete
suppression of PKC activity by TPA pretreatment, we dem-
onstrated that TPA pretreatment completely blocked induc-
tion of c-fos mRNA by phorbol 12,13-dibutyrate (PDBU),
which was reported to be induced by PKC-dependent mech-
anisms [11,20]. TPA pretreatment had no e¡ect on the accu-
Fig. 1. E¡ect of H2O2 on ¢bronectin, p105 coactivator and ECA39
mRNA expressions in VSMC. Northern blot analyses were per-
formed using 20 Wg total RNA isolated from VSMC before and
after 3 h treatment with 200 WM H2O2. Similar results were ob-
tained with three independent experiments.
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mulation of ¢bronectin, p105 coactivator and ECA39 mRNA
by H2O2. Thus, it seems that ROS-induced activation of these
three genes is not mediated by PKC activation.
To examine whether the ROS-regulated genes we identi¢ed
are implicated in the development of atherosclerosis, immu-
nohistostaining for p105 coactivator was performed in bal-
loon-injured rat carotid arteries. At 14 days after injury, the
intima was markedly thickened and p105 coactivator expres-
sion was markedly induced in the neointima of injured arteries
as compared with uninjured control (Fig. 3). No immuno-
reactivity can be seen with normal rabbit serum in the left
carotid artery 14 days after injury (data not shown).
4. Discussion
Proliferation of VSMC constitutes a key step in the devel-
opment of atherosclerosis. Although various growth factors
and oncogenes have been suggested to be involved in the
regulation of VSMC proliferation, the overall mechanism
for the development of atherosclerosis remains poorly eluci-
dated. Recently, ROS have been found to be related to VSMC
proliferation. The induction of ROS has often been observed
in vivo under certain conditions such as hypertension [1], hy-
percholesterolemia [2] and diabetes [3] and recent data suggest
that ROS may play an important role in the development of
atherosclerosis. In this study, we focused on oxidative stress as
a cause of atherosclerosis and sought to identify factors which
may mediate ROS-induced VSMC proliferation. Identi¢cation
of the factors involved in the oxidative stress-mediated athe-
rosclerosis may lead to understanding of the mechanism for
the development of atherosclerosis and enable e⁄cient preven-
tion.
The pathophysiological signi¢cance of the three ROS-in-
duced genes newly identi¢ed in this study remains to be clari-
¢ed. Previous studies revealed that ¢bronectin promotes the
migration of VSMC and its mRNA level is increased in athe-
rosclerotic lesion [21]. It was also reported that the ¢bronectin
gene expression is induced in the smooth muscle cells in the
balloon injury model in which large amount of ROS are pro-
duced [22]. Therefore, as the ¢bronectin gene is activated in
response to ROS in VSMC, ROS-mediated ¢bronectin expres-
sion is likely to explain in part the cause of atherosclerosis.
Here, we would like to note that the ROS-responsive ¢bro-
nectin gene expression was recently found in the mesangial
cells of the kidney [23]. Considering the developmental, bio-
logical and functional similarities between the mesangial cells
in kidney and VSMC, a similar mechanism is likely to operate
in the ROS activation of the ¢bronectin gene in those two
cells.
Rat p105 coactivator is a homologue of human p100 coac-
tivator, which binds c-Myb and regulates its activity [24,25].
Suppression of its expression with antisense oligonucleotide
has been shown to cause reduction in cell growth [26]. In
the present study, the expression of p105 coactivator protein
was shown in the neointima of balloon-injured rat carotid
arteries. This suggests that p105 coactivator is involved in
cell growth and supports the idea that ROS-activated expres-
sion of p105 coactivator may contribute to the VSMC growth
and proliferation.
The ECA39 gene is known to bear a functional c-Myc-bind-
ing sequence located 3P to its transcription start site and regu-
lated by c-Myc [27]. Because the c-myc gene is also ROS-
responsive, the ROS-induced c-myc gene activation may me-
diate ROS-responsive ECA39 expression. Recently, the prod-
uct of ECA39 has been reported to be involved in control of
the cell cycle, suppressing the G1 to S transition in the cell
cycle and eventually leading to apoptosis [28]. Thus, although
in this study, the expression of ECA39 protein in atheroscle-
rotic lesion was not shown due to unavailability of ECA39
antibody, ROS-mediated ECA39 expression may explain in
Fig. 2. (A) Time course of H2O2-induced ¢bronectin, p105 coactiva-
tor and ECA39 mRNA expressions in VSMC. Total RNA was iso-
lated from VSMC treated for the indicated times with 200 WM
H2O2 and Northern blot analyses were performed. (B) Dose-de-
pendent induction of ¢bronectin, p105 coactivator and ECA39
mRNA expressions in VSMC. Total RNA was isolated from
VSMC treated with 0, 50, 100 or 200 WM H2O2 for 3 h and North-
ern blot analyses were performed. (C) E¡ect of TPA pretreatment
on H2O2-induced ¢bronectin, p105 coactivator and ECA39 mRNA
expressions. For the evaluation of ¢bronectin, p105 coactivator and
ECA39 mRNA expressions, VSMC were treated as follows (lane 1^
5, from left to right): lane 1, no additions; lane 2, H2O2 (200 WM)
alone for 1 h (¢bronectin) or 3 h (ECA39 and p105 coactivator);
lane 3, TPA (100 nM) alone for 1 h (¢bronectin) or 3 h (ECA39
and p105 coactivator); lane 4, TPA (100 nM) alone for 24 h; lane
5, TPA (100 nM) alone for 24 h, followed by H2O2 (200 WM) for
1 h (¢bronectin) or 3 h (ECA39 and p105 coactivator). For the
evaluation of c-fos mRNA expression as a control, VSMC were
made quiescent by incubation in fresh DMEM containing 0.4%
FCS for 48 h before TPA pretreatment. VSMC were treated as fol-
lows (lane 1^5, from left to right): lane 1, quiescent, no additions;
lane 2, TPA (100 nM) alone for 1 h; lane 3, TPA (100 nM) alone
for 24 h; lane 4, TPA (100 nM) alone for 24 h, followed by PDBU
(200 nM) 1 h; lane 5, PDBU (200 nM) alone for 1 h. Total RNA
was isolated from VSMC and Northern blot analyses were per-
formed. Similar results were obtained with three independent experi-
ments.
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part the induction of apoptosis of VSMC, which can be ob-
served in atherosclerotic lesions.
Because oxidant-mediated activation of PKC in VSMC has
been reported and PKC has been known to play an important
role in the expressions of various genes [11,20,29], we inves-
tigated whether PKC is implicated in the ROS-regulated ex-
pression of those three genes. Although the results suggested
that ROS-induced activation of these three genes is not medi-
ated by PKC (Fig. 2C), it remains to be elucidated how ROS
can be the activator of the three genes identi¢ed in this study.
Included among the transcription factors known to mediate
ROS-responsive gene activation are AP-1 [30], NF-kB [31]
and CArG box-binding factor [32]. Among these, only the
AP-1-binding site sequence can be seen in the promoter region
of the ¢bronectin gene [33]. In terms of the rat p105 coacti-
vator and ECA39 genes, no information is available to date
with respect to their promoter structures. Further e¡orts are
needed to clarify the mechanisms underlying the ROS regu-
lation of those genes.
In summary, we identi¢ed ROS-mediated potentially im-
portant factors for the development of atherosclerosis in
VSMC by using the SSH technique. These results suggest
that ROS may play an important role in the development of
atherosclerosis by regulating these gene expressions.
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